[Item 5.07. ach of the seven (7) director-nominees: Name of Nominee Votes For Votes Withheld Weibing Lu 3,175,125 9,912 Wei Wen 3,175,125 9,912 Mark D. Chen 3,043,441 141,596 R.ott Cramer 3,175,125 9,912 Qiang Fan 3,177,079 7,958 Chengtun Qu 3,182,079 2,958 Shouguo Zhao 3,177,079 7,958ystar Bio-Pharmaceuticalmpany Weibing Lu Chief Executive Officer]
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 22, 2010 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 Item 5.07. Submission of Matters to a Vote of Security]
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 22, 2010 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 Item 5.07. Submission of Matters to a Vote of Security]
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the liabilities of]
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the liabilities of]
[bspm13g.txt 1 13G]
